-
Keegan L, Keegan GT. Osteoporosis and soy products. Altern Ther Women's Health 2005;7(4):25-30.
-
Hardy ML. Oh, my aching back: What's a mother to do? Altern Ther Women's Health 2005;7(4):30-31.
-
Cost concerns turning more Americans to CAM therapies. Altern Ther Women's Health 2005;7(4):32.
-
The annual conference of the American College of Cardiology (ACC, Bethesda, Maryland), held here in early March, provided a forum for the announcement of a number of important new developments in the global cardiovascular device market.
-
Cardiovascular Device Update, quite obviously, focuses on devices and instrumentation used in the cardiovascular field, but these areas frequently interlock with both drug and other non-drug technologies.
-
Emerging Asian viruses get a lot of attention, be they severe acute respiratory syndrome or fresh flu strains. But new, or at last newly discovered, viruses can be found in far less exotic locales. New Haven, Connecticut, for example.
-
Cardiac rhythm management company ELA Medical (Monrouge, France) last month reported the European release of Symphony AAIsafeR 2, its second-generation pacemaker that minimizes ventricular pacing. The company said the AAIsafeR 2 pacing mode is intended to promote the patients intrinsic electrical conduction by drastically limiting the amo- unt of unnecessary, often deleterious pacing delivered to the right ventricle.
-
Cardiac Science (Irvine, California), a maker of automatic public-access automated external defibrillators (AEDs), reported last month that it plans to merge with Quinton Cardiology Systems (Bothell, Washington) in order to better leverage distribution and marketing operations.
-
GenVec (Gaithersburg, Maryland) last month reported the launch of a Phase IIB randomized, placebo-controlled trial of its BioBypass angiogen for the treatment of severe coronary artery disease. The NOVA (NOGA Delivery of VEGF for Angina) trial will evaluate the effects of BioBypass on exercise tolerance, heart function, symptoms and quality of life in about 129 patients suffering from moderate to severe chest pain due to advanced coronary artery disease.
-
Alliance Medical (Phoenix), a reprocessor of single-use medical devices (SUDs), reported that Premier Purchasing Partners (San Diego), has signed a three-year agreement with the company to offer medical device reprocessing services to Premiers hospital members.
